Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer

PurposeThe purpose of present study was to investigate the methylation status of the promoter region in five genes (mothers against decapentaplegic homolog 4, fragile histidine triad protein, death-associated protein kinase 1, adenomatous polyposis coli (APC), and E-cadherin), which are known to be involved in the pathogenesis of colorectal cancer (CRC) and its clinicopathological significance.MethodsThe study subjects were 60 CRC patients, 40 patients with adenomatous colorectal polyp and 60 healthy control individuals. We further enrolled a total of 16 patients (two patients with Crohn’s disease, two patients with ulcerative colitis, one patient with serrated adenoma, and 11 patients with colorectal cancer). The methylation states of the five genes were determined in peripheral blood plasma using methylation-specific polymerase chain reaction single-strand conformation polymorphism analysis.ResultsThis study showed the most sensitive epigenetic markers, E-cadherin (60 %), followed by APC (57 %), for detecting CRC. E-cadherin and APC had similar specificities and amplified 84 and 86 %, respectively, of CRC patients compared to non-CRC patients. Additionally, APC was the only marker to be significantly increased (OR = 6.67, 95 % CI = 1.19–23.4, P = 0.045) and the most sensitive (57 %) and specific (89 %) marker in stage I CRC. Though we have not examined the paired cancer tissues and plasma, there was relatively high concordant rate (60–80 %) in our limited number of colorectal cancer patients.ConclusionsFive genes, promoter methylation, in plasma were statistically significant risk factors in CRC patients. In this study, E-cad and APC genes may be particularly useful epigenetic biomarkers in plasma for the detection of CRC. Additionally, APC may able to identify early potential CRC.

[1]  David Sidransky,et al.  DNA methylation markers in colorectal cancer , 2010, Cancer and Metastasis Reviews.

[2]  Joobae Park,et al.  Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer , 2009, Clinical Cancer Research.

[3]  A. Cheung,et al.  Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. , 2004, Gynecologic oncology.

[4]  Bela Molnar,et al.  DNA methylation biomarkers for blood-based colorectal cancer screening. , 2008, Clinical chemistry.

[5]  G. Giaccone,et al.  FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.

[6]  Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. , 2010, Cancer research.

[7]  K. Seferiadis,et al.  Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas. , 2010, World journal of gastroenterology.

[8]  M. Melhem,et al.  FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: An immunohistochemical and image analysis study , 2004, Clinical & Experimental Metastasis.

[9]  C. Croce,et al.  Structure and expression of the human FHIT gene in normal and tumor cells. , 1997, Cancer research.

[10]  Toshio Kuroki,et al.  Role of Smad4 (DPC4) inactivation in human cancer. , 2003, Biochemical and biophysical research communications.

[11]  B. Balluff,et al.  Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions , 2010, PloS one.

[12]  A. Kimchi,et al.  DAPk Protein Family and Cancer , 2006, Autophagy.

[13]  A. Kinsella,et al.  Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines , 1994, Clinical & Experimental Metastasis.

[14]  C. Moon,et al.  Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer , 2004, Clinical Cancer Research.

[15]  K. Mimori,et al.  Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma. , 2001, Cancer research.

[16]  S. Groshen,et al.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. , 2000, Journal of the National Cancer Institute.

[17]  Tsutomu Yoshida,et al.  Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender , 2009, Journal of Gastroenterology.

[18]  T. P. Pretlow,et al.  Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. , 2000, Cancer research.

[19]  S. Patra,et al.  Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review). , 2007, Oncology reports.

[20]  D. Douek,et al.  In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule Proteins , 2005, Clinical Cancer Research.

[21]  A. Fendrick,et al.  Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.

[22]  Steven Piantadosi,et al.  DNA methylation markers and early recurrence in stage I lung cancer. , 2008, The New England journal of medicine.

[23]  Arnulf H Hölscher,et al.  Loss of Smad4 correlates with loss of the invasion suppressor E‐cadherin in advanced colorectal carcinomas , 2004, The Journal of pathology.

[24]  T. Godfrey,et al.  Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. , 2005, Clinical chemistry.

[25]  G. Deng,et al.  Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. , 2007, Gut and liver.

[26]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[27]  Keitaro Matsuo,et al.  Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  R. Malekzadeh,et al.  Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker , 2009, BMC Cancer.

[29]  E. Morselli,et al.  Control of autophagy by oncogenes and tumor suppressor genes , 2009, Cell Death and Differentiation.